GSK’s Veramyst To Launch By Late May
This article was originally published in The Pink Sheet Daily
Executive Summary
Flonase follow-on is indicated for treatment of seasonal and perennial allergic rhinitis in adults and children two years of age and older.
You may also be interested in...
Collegium Poised To Re-Launch Nasal Spray As AllerNase In 2008
Firm is also working on reformulations of Forest/Cypress’ investigational serotonin-norepinephrine reuptake inhibitor milnacipran in Phase III development for treatment of fibromyalgia.
Collegium Poised To Re-Launch Nasal Spray As AllerNase In 2008
Firm is also working on reformulations of Forest/Cypress’ investigational serotonin-norepinephrine reuptake inhibitor milnacipran in Phase III development for treatment of fibromyalgia.
Nasonex, Flonase Detail Aids Make Unproven Superiority Claims - DDMAC Letter
FDA asks Schering-Plough, GlaxoSmithKline to pull detail material containing “unsubstantiated,” and “false and misleading” claims.